ArticleJournal of hepatocellular carcinoma2014

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models.

Lynne Braidwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.